Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Published:2021-04 Issue: Volume:Volume 10 Page:123-140
ISSN:2253-1556
Container-title:ImmunoTargets and Therapy
language:en
Short-container-title:ITT

Author:

Xu Ning,Tse Benjamin,Yang Lu,Tang Tiffany CY,Haber Michelle^ORCID,Micklethwaite Kenneth,Dolnikov Alla

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

4. The Basic Principles of Chimeric Antigen Receptor Design

5. Mechanisms of resistance to CAR T cell therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Prospects for Targeting the Epigenome in Lymphomas;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

2. Epigenetic reprogramming in cancer: From diagnosis to treatment;Frontiers in Cell and Developmental Biology;2023-02-14

3. MSCs interaction with the host lung microenvironment: An overlooked aspect?;Frontiers in Immunology;2022-11-15

4. Donor T cells for CAR T cell therapy;Biomarker Research;2022-04-01

5. Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia;Cancers;2021-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP